Skip to content

Drug interactions

Crizotinib + Selumetinib

Severity: Moderate

Crizotinib and Selumetinib: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Selumetinib is metabolized mainly by CYP3A4, and crizotinib may increase its exposure. This may increase adverse effects such as gastrointestinal toxicity, rash and cardiomyopathy.

What this interaction means in plain words

Crizotinib and Selumetinib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Crizotinib belongs to Oncology; Selumetinib belongs to Oncology.

Evidence level: Moderate

Why it happens

Crizotinib inhibits CYP3A4 metabolism of selumetinib.

What to do

If unavoidable, reduce the selumetinib dose per labeling for moderate CYP3A inhibitors. Monitor tolerability and resume the previous dose after crizotinib is stopped.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Crizotinib and Selumetinib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Crizotinib with Selumetinib?

MediHelp rates the interaction as moderate. Crizotinib and Selumetinib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Selumetinib is metabolized mainly by CYP3A4, and crizotinib may increase its exposure. This may increase adverse effects such as gastrointestinal toxicity, rash and cardiomyopathy.

How serious is the interaction between Crizotinib and Selumetinib?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: If unavoidable, reduce the selumetinib dose per labeling for moderate CYP3A inhibitors. Monitor tolerability and resume the previous dose after crizotinib is stopped.

What other medicines interact with Crizotinib?

MediHelp also lists interactions of Crizotinib with, for example, Flibanserin, Lomitapide, Lonafarnib. The full list is on the Crizotinib page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in